LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase

被引:58
作者
Marti, F
Xu, CW
Selvakumar, A
Brent, R
Dupont, B
King, PD
机构
[1] Cornell Univ, Hosp Special Surg, Med Ctr, Div Rheumatol,Res Lab 317, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA
[3] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA
关键词
D O I
10.1073/pnas.95.20.11810
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HLA-specific killer cell inhibitory receptors (KIR) are thought to impede natural killer (NK) and T cell activation programs through recruitment of the SH2 domain-containing tyrosine phosphatases, SHP-1 and SHP-2, to their cytoplasmic tails (CYT). To identify other SH2 domain-containing proteins that bind KIR CYT, we used the recently described yeast two-bait interaction trap and a modified version of this system, both of which permit tyrosine phosphorylation of bait proteins, Using these systems, we show that KIR CYT, once phosphorylated by the src-family tyrosine kinase LCK, additionally bind the p85 alpha regulatory subunit of phosphatidylinositol (PI) 3-kinase. Furthermore, we show that in an NK cell line, NK3.3, cross-linking of KIR results in recruitment of p85 alpha to KIR and activation of PI 3-kinase lipid kinase activity. One consequence of KIR coupling to PI 3-kinase is downstream activation of the antiapoptotic protein kinase AKT. Therefore, in addition to providing negative signals, KIR may also contribute positive signals for NK and T cell growth and/or survival.
引用
收藏
页码:11810 / 11815
页数:6
相关论文
共 41 条
[1]  
Arm JP, 1997, J IMMUNOL, V159, P2342
[2]   MOLECULAR-CLONING OF A CD28 CDNA BY A HIGH-EFFICIENCY COS CELL EXPRESSION SYSTEM [J].
ARUFFO, A ;
SEED, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8573-8577
[3]   The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions [J].
Biassoni, R ;
Cantoni, C ;
Falco, M ;
Verdiani, S ;
Bottino, C ;
Vitale, M ;
Conte, R ;
Poggi, A ;
Moretta, A ;
Moretta, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :645-650
[4]   Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation [J].
Binstadt, BA ;
Brumbaugh, KM ;
Dick, CJ ;
Scharenberg, AM ;
Williams, BL ;
Colonna, M ;
Lanier, LL ;
Kinet, JP ;
Abraham, RT ;
Leibson, PJ .
IMMUNITY, 1996, 5 (06) :629-638
[5]   NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor [J].
Brooks, AG ;
Posch, PE ;
Scorzelli, CJ ;
Borrego, F ;
Coligan, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :795-800
[6]   Phosphoinositide kinases [J].
Carpenter, CL ;
Cantley, LC .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (02) :153-158
[7]   A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules [J].
Cosman, D ;
Fanger, N ;
Borges, L ;
Kubin, M ;
Chin, W ;
Peterson, L ;
Hsu, ML .
IMMUNITY, 1997, 7 (02) :273-282
[8]   Three-part inventions: Intracellular signaling and induced proximity [J].
Crabtree, GR ;
Schreiber, SL .
TRENDS IN BIOCHEMICAL SCIENCES, 1996, 21 (11) :418-422
[9]   Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment [J].
Cyster, JG ;
Goodnow, CC .
IMMUNITY, 1997, 6 (05) :509-517
[10]  
Eischen CM, 1996, J IMMUNOL, V156, P2693